{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:59:24Z","timestamp":1769554764553,"version":"3.49.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009591","name":"Ministerium f\u00fcr Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009591","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"German Federal Ministry of Education and Research","award":["BMBF 01EO1503"],"award-info":[{"award-number":["BMBF 01EO1503"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZA 639\/4-1"],"award-info":[{"award-number":["ZA 639\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["JU 2735\/2-1"],"award-info":[{"award-number":["JU 2735\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Maastricht University Medical Centre, Cardiovascular Centre"},{"name":"Centre for Molecular Translational Medicine"},{"name":"European Union's Horizon 2020","award":["Marie Sklodowska-Curie grant agreement No. 766118"],"award-info":[{"award-number":["Marie Sklodowska-Curie grant agreement No. 766118"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients diagnosed with pseudohypoparathyroidism type Ia (PHP Ia) suffer from hormonal resistance and abnormal postural features, in a condition classified as Albright hereditary osteodystrophy (AHO) syndrome. This syndrome is linked to a maternally inherited mutation in the <jats:italic>GNAS<\/jats:italic> complex locus, encoding for the GTPase subunit Gs\u03b1. Here, we investigated how platelet phenotype and omics analysis can assist in the often difficult diagnosis. By coupling to the IP receptor, Gs\u03b1 induces platelet inhibition via adenylyl cyclase and cAMP-dependent protein kinase A (PKA). In platelets from seven patients with suspected AHO, one of the largest cohorts examined, we studied the PKA-induced phenotypic changes. Five patients with a confirmed <jats:italic>GNAS<\/jats:italic> mutation, displayed impairments in Gs\u03b1-dependent VASP phosphorylation, aggregation, and microfluidic thrombus formation. Analysis of the platelet phosphoproteome revealed 2,516 phosphorylation sites, of which 453 were regulated by Gs\u03b1-PKA. Common changes in the patients were: (1) a joint panel of upregulated and downregulated phosphopeptides; (2) overall PKA dependency of the upregulated phosphopeptides; (3) links to key platelet function pathways. In one patient with <jats:italic>GNAS<\/jats:italic> mutation, diagnosed as non-AHO, the changes in platelet phosphoproteome were reversed. This combined approach thus revealed multiple phenotypic and molecular biomarkers to assist in the diagnosis of suspected PHP Ia.<\/jats:p>","DOI":"10.1038\/s41598-020-68379-3","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T10:06:38Z","timestamp":1594289198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Impaired iloprost-induced platelet inhibition and phosphoproteome changes in patients with confirmed pseudohypoparathyroidism type Ia, linked to genetic mutations in GNAS"],"prefix":"10.1038","volume":"10","author":[{"given":"Frauke","family":"Swieringa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorella A.","family":"Solari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Pagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingnan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion A. H.","family":"Feijge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Jurk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene M. L. W.","family":"K\u00f6rver-Keularts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine J. A.","family":"Mattheij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Faber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Pohlenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie T. R. M.","family":"Stumpel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk E.","family":"Schrander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Zieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola E. J.","family":"van der Meijden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 P.","family":"Zahedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Sickmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan W. M.","family":"Heemskerk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"68379_CR1","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1210\/jc.2011-1048","volume":"96","author":"G Mantovani","year":"2011","unstructured":"Mantovani, G. Pseudohypoparathyroidism: diagnosis and treatment. J. Clin. Endocrinol. Metab. 96, 3020\u20133030 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"68379_CR2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","volume":"14","author":"G Mantovani","year":"2018","unstructured":"Mantovani, G. et al. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat. Rev. Endocrinol. 14, 476\u2013500 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"68379_CR3","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1073\/pnas.85.7.2081","volume":"85","author":"T Kozasa","year":"1988","unstructured":"Kozasa, T., Itoh, H., Tsukamoto, T. & Kaziro, Y. Isolation and characterization of the human Gs alpha gene. Proc. Natl. Acad. Sci. USA. 85, 2081\u20132085 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"68379_CR4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/epi.2.4.5380","volume":"4","author":"J Peters","year":"2007","unstructured":"Peters, J. & Williamson, C. M. Control of imprinting at the Gnas cluster. Epigenetics 4, 207\u2013213 (2007).","journal-title":"Epigenetics"},{"key":"68379_CR5","doi-asserted-by":"crossref","unstructured":"International Consortium for Blood Pressure Genome-Wide Association Studies et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478, 103\u2013109 (2011).","DOI":"10.1038\/nature10405"},{"key":"68379_CR6","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1172\/JCI11887","volume":"107","author":"BE Hayward","year":"2001","unstructured":"Hayward, B. E. et al. Imprinting of the Gsa gene GNAS1 in the pathogenesis of acromegaly. J. Clin. Invest. 107, R21\u2013R36 (2001).","journal-title":"J. Clin. Invest."},{"key":"68379_CR7","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1186\/s13148-016-0175-8","volume":"8","author":"A Rochtus","year":"2016","unstructured":"Rochtus, A. et al. Genome-wide DNA methylation analysis of pseudohypoparathyroidism patients with GNAS imprinting defects. Clin. Epigenetics 8, e10 (2016).","journal-title":"Clin. Epigenetics"},{"key":"68379_CR8","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","volume":"85","author":"N Wettschureck","year":"2005","unstructured":"Wettschureck, N. & Offermanns, S. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85, 1159\u20131204 (2005).","journal-title":"Physiol. Rev."},{"key":"68379_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1152\/physrev.00021.2003","volume":"84","author":"K Tasken","year":"2004","unstructured":"Tasken, K. & Aandahl, E. M. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev. 84, 137\u2013167 (2004).","journal-title":"Physiol. Rev."},{"key":"68379_CR10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/B978-012369367-9\/50775-8","volume-title":"Platelets","author":"S Rex","year":"2007","unstructured":"Rex, S. & Freedman, J. E. Inhibition of platelet function by the endothelium. In Platelets (ed. Michelson, A. D.) 251\u2013279 (Elsevier, Amsterdam, 2007)."},{"key":"68379_CR11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","volume":"93","author":"HH Versteeg","year":"2013","unstructured":"Versteeg, H. H., Heemskerk, J. W., Levi, M. & Reitsma, P. S. New fundamentals in hemostasis. Physiol. Rev. 93, 327\u2013358 (2013).","journal-title":"Physiol. Rev."},{"key":"68379_CR12","first-page":"166","volume":"16","author":"PE Van der Meijden","year":"2019","unstructured":"Van der Meijden, P. E. & Heemskerk, J. W. Platelet biology and functions: new concepts and future clinical perspectives Nat. Rev. Cardiol. 16, 166\u2013179 (2019).","journal-title":"Rev. Cardiol."},{"key":"68379_CR13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bcp.2012.03.012","volume":"84","author":"BJ Whittle","year":"2012","unstructured":"Whittle, B. J., Silverstein, A. M., Mottola, D. M. & Clapp, L. H. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist. Biochem. Pharmacol. 84, 68\u201375 (2012).","journal-title":"Biochem. Pharmacol."},{"key":"68379_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.blre.2013.12.001","volume":"28","author":"F Swieringa","year":"2014","unstructured":"Swieringa, F., Kuijpers, M. J., Heemskerk, J. W. & van der Meijden, P. E. Targeting platelet receptor function in thrombus formation: the risk of bleeding. Blood Rev. 28, 9\u201321 (2014).","journal-title":"Blood Rev."},{"key":"68379_CR15","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.bcp.2003.12.028","volume":"67","author":"MA Feijge","year":"2004","unstructured":"Feijge, M. A., Ansink, K., Vanschoonbeek, K. & Heemskerk, J. W. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Biochem. Pharmacol. 67, 1559\u20131567 (2004).","journal-title":"Biochem. Pharmacol."},{"key":"68379_CR16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1538-7933.2004.00618.x","volume":"2","author":"K Vanschoonbeek","year":"2004","unstructured":"Vanschoonbeek, K. et al. Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. J. Thromb. Haemost. 2, 476\u2013484 (2004).","journal-title":"J. Thromb. Haemost."},{"key":"68379_CR17","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1210\/jc.2008-0883","volume":"93","author":"K Freson","year":"2008","unstructured":"Freson, K. et al. GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in platelets. J. Clin. Endocrinol. Metab. 93, 4851\u20134859 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"68379_CR18","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1182\/blood-2012-04-416594","volume":"120","author":"JM Burkhart","year":"2012","unstructured":"Burkhart, J. M. et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 120, e73\u2013e82 (2012).","journal-title":"Blood"},{"key":"68379_CR19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2013-07-512384","volume":"123","author":"F Beck","year":"2014","unstructured":"Beck, F. et al. Time-resolved characterization of cAMP\/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways. Blood 123, e1\u2013e10 (2014).","journal-title":"Blood"},{"key":"68379_CR20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.114.301598","volume":"114","author":"JM Burkhart","year":"2014","unstructured":"Burkhart, J. M. et al. What can proteomics tell us about platelets?. Circ. Res. 114, 1204\u20131219 (2014).","journal-title":"Circ. Res."},{"key":"68379_CR21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14789450.2018.1480111","volume":"15","author":"C Loosse","year":"2018","unstructured":"Loosse, C., Swieringa, F., Heemskerk, J. W. & Sickmann, A. Platelet proteomics: from discovery to diagnosis. Exp. Rev. Proteomics 15, 467\u2013476 (2018).","journal-title":"Exp. Rev. Proteomics"},{"key":"68379_CR22","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/s-0037-1614344","volume":"82","author":"UR Schwarz","year":"1999","unstructured":"Schwarz, U. R., Geiger, J., Walter, U. & Eigenthaler, M. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets: definition and detection of ticlopidine\/clopidogrel effects. Thromb. Haemost. 82, 1145\u20131152 (1999).","journal-title":"Thromb. Haemost."},{"key":"68379_CR23","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1182\/blood-2012-07-444281","volume":"120","author":"BB Dawood","year":"2012","unstructured":"Dawood, B. B. et al. Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonst panel. Blood 120, 5041\u20135049 (2012).","journal-title":"Blood"},{"key":"68379_CR24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3324\/haematol.2018.198853","volume":"104","author":"JP Van Geffen","year":"2019","unstructured":"Van Geffen, J. P. et al. High-throughput elucidation of thrombus formation reveals sources of platelet function variability. Haematologica 104, 1256\u20131267 (2019).","journal-title":"Haematologica"},{"key":"68379_CR25","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/ncomms5257","volume":"5","author":"SM De Witt","year":"2014","unstructured":"De Witt, S. M. et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat. Commun. 5, 4257 (2014).","journal-title":"Nat. Commun."},{"key":"68379_CR26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3324\/haematol.2017.176974","volume":"103","author":"M Nagy","year":"2018","unstructured":"Nagy, M. et al. Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies. Haematologica 103, 540\u2013549 (2018).","journal-title":"Haematologica"},{"key":"68379_CR27","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1074\/mcp.M116.060368","volume":"15","author":"FA Solari","year":"2016","unstructured":"Solari, F. A. et al. Combined quantification of the global proteome, phosphoproteome, and proteolytic cleavage to characterize altered platelet functions in the human Scott syndrome. Mol. Cell. Proteomics 15, 3154\u20133169 (2016).","journal-title":"Mol. Cell. Proteomics"},{"key":"68379_CR28","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1210\/jc.2013-3086","volume":"99","author":"FM Elli","year":"2014","unstructured":"Elli, F. M. et al. Quantitative analysis of methylation defects and correlation with clinical characteristics in patients with pseudohypoparathyroidism type I and GNAS epigenetic alterations. J. Clin. Endocrino. l Metab. 99, e508\u2013e517 (2014).","journal-title":"J. Clin. Endocrino. l Metab."},{"key":"68379_CR29","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/jhg.2012.1","volume":"57","author":"B Izzi","year":"2012","unstructured":"Izzi, B. et al. No evidence for GNAS copy number variants in patients with features of Albright\u2019s hereditary osteodystrophy and abnormal platelet Gs activity. J. Hum. Genet. 57, 277\u2013279 (2012).","journal-title":"J. Hum. Genet."},{"key":"68379_CR30","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2013-03-487850","volume":"122","author":"A Aburima","year":"2013","unstructured":"Aburima, A. et al. cAMP signaling regulates platelet myosin-light chain (MLC) phosphorylation and shape change through targeting the Rho-A-Rho kinase-MLC phosphatase signaling pathway. Blood 122, 3533\u20133545 (2013).","journal-title":"Blood"},{"key":"68379_CR31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/bj2710815","volume":"271","author":"W Siess","year":"1990","unstructured":"Siess, W. & Lapetina, E. G. Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition. Biochem. J. 271, 815\u2013819 (1990).","journal-title":"Biochem. J."},{"key":"68379_CR32","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2016-05-714048","volume":"129","author":"F Beck","year":"2017","unstructured":"Beck, F. et al. Temporal quantitative phosphoproteomics of ADP stimulation reveals novel central nodes in platelet activation and inhibition. Blood 129, e1\u2013e12 (2017).","journal-title":"Blood"},{"key":"68379_CR33","doi-asserted-by":"crossref","first-page":"18352","DOI":"10.1074\/jbc.M109.077602","volume":"285","author":"S Gambaryan","year":"2010","unstructured":"Gambaryan, S. et al. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J. Biol. Chem. 285, 18352\u201318363 (2010).","journal-title":"J. Biol. Chem."},{"key":"68379_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1538-7836.2011.04576.x","volume":"10","author":"A Smolenski","year":"2012","unstructured":"Smolenski, A. Novel roles of cAMP\/cGMP-dependent signaling in platelets. J. Thromb. Haemost. 10, 167\u2013176 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"68379_CR35","doi-asserted-by":"crossref","first-page":"33750","DOI":"10.1074\/jbc.M109.048439","volume":"284","author":"K Gilio","year":"2009","unstructured":"Gilio, K. et al. Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation. J. Biol. Chem. 284, 33750\u201333762 (2009).","journal-title":"J. Biol. Chem."},{"key":"68379_CR36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2133.2009.09543.x","volume":"162","author":"M Klaassens","year":"2010","unstructured":"Klaassens, M. et al. Unique skin changes in a case of Albright hereditary osteodystrophy caused by a rare GNAS1 mutation. Br. J. Dermatol. 162, 690\u2013694 (2010).","journal-title":"Br. J. Dermatol."},{"key":"68379_CR37","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199005173222002","volume":"322","author":"JL Patten","year":"1990","unstructured":"Patten, J. L. et al. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright\u2019s hereditary osteodystrophy. N. Engl. J. Med. 322, 1412\u20131419 (1990).","journal-title":"N. Engl. J. Med."},{"key":"68379_CR38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/eje.0.1480463","volume":"148","author":"J Pohlenz","year":"2003","unstructured":"Pohlenz, J., Ahrens, W. & Hiort, O. A new heterozygous mutation (L338N) in the human Gsalpha (GNAS1) gene as a cause for congenital hypothyroidism in Albright\u2019s hereditary osteodystrophy. Eur. J. Endocrinol. 148, 463\u2013468 (2003).","journal-title":"Eur. J. Endocrinol."},{"key":"68379_CR39","doi-asserted-by":"crossref","first-page":"23629","DOI":"10.1074\/jbc.M110.108696","volume":"285","author":"K Gilio","year":"2010","unstructured":"Gilio, K. et al. Roles of STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J. Biol. Chem. 285, 23629\u201323638 (2010).","journal-title":"J. Biol. Chem."},{"key":"68379_CR40","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1074\/jbc.275.3.1763","volume":"275","author":"IM Keularts","year":"2000","unstructured":"Keularts, I. M., van Gorp, R. M., Feijge, M. A., Vuist, M. W. & Heemskerk, J. W. a2A-Adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. J. Biol. Chem. 275, 1763\u20131772 (2000).","journal-title":"J. Biol. Chem."},{"key":"68379_CR41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/09537104.2011.630848","volume":"23","author":"R Van Kruchten","year":"2012","unstructured":"Van Kruchten, R., Cosemans, J. M. & Heemskerk, J. W. Measurement of whole blood thrombus formation using parallel-plate flow chambers: a practical guide. Platelets 23, 229\u2013242 (2012).","journal-title":"Platelets"},{"key":"68379_CR42","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3324\/haematol.2014.116863","volume":"100","author":"F Swieringa","year":"2015","unstructured":"Swieringa, F., Kuijpers, M. J., Lamers, M. M., van der Meijden, P. E. & Heemskerk, J. W. Rate-limiting roles of tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow. Haematologica 100, 748\u2013756 (2015).","journal-title":"Haematologica"},{"key":"68379_CR43","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1016\/j.jprot.2012.08.007","volume":"75","author":"K Engholm-Keller","year":"2012","unstructured":"Engholm-Keller, K. et al. TiSH: a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC. J. Proteomics 75, 5749\u20135761 (2012).","journal-title":"J. Proteomics"},{"key":"68379_CR44","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1021\/pr300247u","volume":"11","author":"M Vaudel","year":"2012","unstructured":"Vaudel, M. et al. Integral quantification accuracy estimation for reporter ion-based quantitative proteomics (iQuARI). J. Proteome Res. 11, 5072\u20135080 (2012).","journal-title":"J. Proteome Res."},{"key":"68379_CR45","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jprot.2011.11.016","volume":"75","author":"JM Burkhart","year":"2012","unstructured":"Burkhart, J. M., Schumbrutzki, C., Wortelkamp, S., Sickmann, A. & Zahedi, R. P. Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomic. J. Proteomics 75, 1454\u20131562 (2012).","journal-title":"J. Proteomics"},{"key":"68379_CR46","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/pmic.200401063","volume":"5","author":"LL Manza","year":"2005","unstructured":"Manza, L. L., Stamer, S. L., Ham, A. J., Codreanu, S. G. & Liebler, D. C. Sample preparation and digestion for proteomic analyses using spin filters. Proteomics 5, 1742\u20131745 (2005).","journal-title":"Proteomics"},{"key":"68379_CR47","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1021\/pr900748n","volume":"8","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski, J. R., Zougman, A. & Mann, M. Combination of FASP and StageTip-based fractionation allows in-depth analysis of the hippocampal membrane proteome. J. Proteome Res. 8, 5674\u20135678 (2009).","journal-title":"J. Proteome Res."},{"key":"68379_CR48","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jprot.2011.11.016","volume":"75","author":"JM Burkhart","year":"2012","unstructured":"Burkhart, J. M., Schumbrutzki, C., Wortelkamp, S., Sickmann, A. & Zahedi, R. P. Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics. J. Proteomics 75, 1454\u20131462 (2012).","journal-title":"J. Proteomics"},{"key":"68379_CR49","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-1-4939-0685-7_28","volume":"1156","author":"C Dickhut","year":"2014","unstructured":"Dickhut, C., Radau, S. & Zahedi, R. P. Fast, efficient, and quality-controlled phosphopeptide enrichment from minute sample amounts using titanium dioxide. Methods Mol. Biol. 1156, 417\u2013430 (2014).","journal-title":"Methods Mol. Biol."},{"key":"68379_CR50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1074\/mcp.M300105-MCP200","volume":"3","author":"MR Larsen","year":"2004","unstructured":"Larsen, M. R., Graham, M. E., Robinson, P. J. & Roepstorff, P. Improved detection of hydrophilic phosphopeptides using graphite powder microcolumns and mass spectrometry: evidence for in vivo doubly phosphorylated dynamin I and dynamin III. Mol. Cell. Proteomics 3, 456\u2013465 (2004).","journal-title":"Mol. Cell. Proteomics"},{"key":"68379_CR51","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1021\/pr100230q","volume":"9","author":"TE Thingholm","year":"2010","unstructured":"Thingholm, T. E., Palmisano, G., Kjeldsen, F. & Larsen, M. R. Undesirable charge-enhancement of isobaric tagged phosphopeptides leads to reduced identification efficiency. J. Proteome Res. 9, 4045\u20134052 (2010).","journal-title":"J. Proteome Res."},{"key":"68379_CR52","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.1021\/pr200611n","volume":"10","author":"T Taus","year":"2011","unstructured":"Taus, T. et al. Universal and confident phosphorylation site localization using phosphoRS. J. Proteome Res. 10, 5354\u20135362 (2011).","journal-title":"J. Proteome Res."},{"key":"68379_CR53","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1074\/mcp.M700574-MCP200","volume":"7","author":"Y Xue","year":"2008","unstructured":"Xue, Y. et al. GPS 2.0, a tool to predict kinase-specific phosphorylation sites in hierarchy. Mol. Cell. Proteomics 7, 1598\u20131608 (2008).","journal-title":"Mol. Cell. Proteomics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68379-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68379-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T14:05:59Z","timestamp":1670335559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68379-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68379"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68379-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"7 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JWMH is co-founder and shareholder of FlowChamber. Other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11389"}}